---
figid: PMC5093919__1413fig1
figlink: /pmc/articles/PMC5093919/figure/fig1/
number: FIGURE 1
caption: PI3K/AKT/mTOR signaling is regulated by intrinsic feedback. With AKT inhibition,
  intrinsic feedback inhibition mechanisms built into AKT signaling pathway are released,
  resulting in increased RTK surface expression and activation, primarily of HER3.
  With PI3K inhibition, same AKT feedback inhibition mechanisms are released; however,
  because of cross-talk between PI3K and MAPK pathway, release of feedback inhibition
  mechanisms along MAPK pathway also contribute to increased RTK expression and activation.
  These feedback patterns are influenced by multiple cellular factors and are thought
  to differ meaningfully across patient tumors, such that degree of change in expression
  cannot be known a priori.
pmcid: PMC5093919
papertitle: Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance.
reftext: Eric Wehrenberg-Klee, et al. J Nucl Med. 2016 Sep;57(9):1413-1419.
pmc_ranked_result_index: '56923'
pathway_score: 0.9307983
filename: 1413fig1.jpg
figtitle: PI3K/AKT/mTOR signaling is regulated by intrinsic feedback
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5093919__1413fig1.html
  '@type': Dataset
  description: PI3K/AKT/mTOR signaling is regulated by intrinsic feedback. With AKT
    inhibition, intrinsic feedback inhibition mechanisms built into AKT signaling
    pathway are released, resulting in increased RTK surface expression and activation,
    primarily of HER3. With PI3K inhibition, same AKT feedback inhibition mechanisms
    are released; however, because of cross-talk between PI3K and MAPK pathway, release
    of feedback inhibition mechanisms along MAPK pathway also contribute to increased
    RTK expression and activation. These feedback patterns are influenced by multiple
    cellular factors and are thought to differ meaningfully across patient tumors,
    such that degree of change in expression cannot be known a priori.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R4
  - FOXO3
  - FOXO4
  - PIK3CB
  - IRS1
  - PIK3R5
  - AKT1
  - FOXO6
  - AKT2
  - IRS4
  - KRAS
  - NRAS
  - IRS2
  - FOXO1
  - PIK3CA
  - PDK2
  - PDK3
  - MAP2K1
  - AKT3
  - HRAS
  - PDK1
  - PIK3CD
  - PIK3R6
  - MAP2K2
  - RAF1
  - PIK3R3
  - PIK3CG
  - MAPK3
  - ARAF
  - BRAF
  - PDK4
  - MAPK1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
